Metastatic Hormone-Sensitive Prostate Cancer: Data From ARASENS and ARANOTE
A panel of medical oncologist reflect on clinical data from the ARASENS and ARANOTE trials utilizing combination strategies with darolutamide in mHSPC.
Source: onclive.com
Stay updated with breaking news from Aranote Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A panel of medical oncologist reflect on clinical data from the ARASENS and ARANOTE trials utilizing combination strategies with darolutamide in mHSPC.